Editors: Gene D. Morse, Sarah Nanzigu

Series Title: Frontiers in HIV Research

Advances in HIV Treatment: HIV Enzyme Inhibitors and Antiretroviral Therapy

Volume 1

eBook: US $39 Special Offer (PDF + Printed Copy): US $106
Printed Copy: US $87
Library License: US $156
ISSN: 2405-9862 (Print)
ISSN: 2405-9889 (Online)
ISBN: 978-1-68108-057-4 (Print)
ISBN: 978-1-68108-056-7 (Online)
Year of Publication: 2015
DOI: 10.2174/97816810805671150101

Introduction

Advances in HIV Treatment: HIV Enzyme Inhibitors and Antiretroviral Therapy presents comprehensive and updated information on drug therapies used to treat and manage HIV infection in human patients. The volume is organized in to chapters detailing respective classes of HIV Drugs including HIV entry inhibitors, reverse transcriptase inhibitors (RTIs), integrase strand inhibitors (INSTIs), and protease inhibitors (PIs). Each chapter compiles background information, pharmacology and clinical aspects such as side effects on the specific classes of drugs represented. Available data for ongoing research for new targets, including vaccines is also presented. Readers will also find a useful introduction to HIV virology and pathogenesis as well as a comparison of the availability and activity of these agents in different populations, opening a discussion on the influence of genetics and resources in curbing the HIV epidemic. Advances in HIV Treatment: HIV Enzyme Inhibitors and Antiretroviral Therapy is, therefore, a holistic resource for researchers, healthcare professionals and clinicians interested in understanding antiretroviral drugs and the management of HIV infection/AIDS. The volume is also of interest to undergraduate and graduate students undertaking specialized courses in pharmacology and HIV/AIDS management.

Contributors

Editor(s):
Gene D. Morse
New York State Center of Excellence in Bioinformatics and Life Sciences
University at Buffalo
Buffalo, Newyork
USA


Sarah Nanzigu
Department of Pharmacology and Therapeutics
Makerere University College of Health Science
Kampala
Uganda




Contributor(s):
Amy Moss
Thomas Street Health Center
Harris Health System
Houston
TX
USA


Cara Felton
School of Pharmacy and Pharmaceutical Sciences
University at Buffalo
Buffalo
NY
USA


Charles S. Venuto
Translational Pharmacology Research Core
New York State Center of Excellence in Bioinformatics and Life Sciences
University at Buffalo
Buffalo
NY
USA
/
School of Pharmacy and Pharmaceutical Sciences
University at Buffalo
Buffalo
NY
USA


Cindy J. Bednasz
Translational Pharmacology Research Core
New York State Center of Excellence in Bioinformatics and Life Sciences
University at Buffalo
Buffalo
NY
USA
/
School of Pharmacy and Pharmaceutical Sciences
University at Buffalo
Buffalo
NY
USA


Francis Xavier Kasujja
Médecins Sans Frontières
Harare
Zimbabwe


Gene D. Morse
Translational Pharmacology Research Core
New York State Center of Excellence in Bioinformatics and Life Sciences
University at Buffalo
Buffalo
NY
USA
/
School of Pharmacy and Pharmaceutical Sciences
University at Buffalo
Buffalo
NY
USA


Immaculate Nankya
Joint Clinic Research Centre
Kampala
Uganda


Jaran Eriksen
Department of Laboratory Medicine, Division of Clinical Phamracology
University Hospital at Huddinge, Karolinska Institutet
Sweden


Joshua R. Sawyer
Translational Pharmacology Research Core
New York State Center of Excellence in Bioinformatics and Life Sciences
University at Buffalo
Buffalo
NY
USA
/
School of Pharmacy and Pharmaceutical Sciences
University at Buffalo
Buffalo
NY
USA
/
Erie County Medical Center Corporation
Buffalo
NY
USA


Kevin Hsu
School of Pharmacy and Pharmaceutical Sciences
University at Buffalo
Buffalo
NY
USA


Moses R. Kamya
School of Medicine
Makerere University College of Health Sciences
Uganda


Pauline Byakika-Kibwika
Department of Medicine, College of Health Sciences
Makerere University
Uganda


Qing Ma
Translational Pharmacology Research Core
New York State Center of Excellence in Bioinformatics and Life Sciences
University at Buffalo
Buffalo
NY
USA
/
School of Pharmacy and Pharmaceutical Sciences
University at Buffalo
Buffalo
NY
USA


Rebecca A. Sumner
Translational Pharmacology Research Core
New York State Center of Excellence in Bioinformatics and Life Sciences
University at Buffalo
Buffalo
NY
USA
/
School of Pharmacy and Pharmaceutical Sciences
University at Buffalo
Buffalo
NY
USA


Sarah Nanzigu
Department of Pharmacology and Therapeutics
Makerere University College of Health Science
Kampala
Uganda




RELATED BOOKS

.COVID 19 – Monitoring with IoT Devices.
.Recent Advances in the Application of Marine Natural Products as Antimicrobial Agents.
.Recent Trends and The Future of Antimicrobial Agents - Part 2.
.COVID-19: Origin, Impact and Management (Part 1).